Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07021716 · ClinicalTrials.gov registry record
COVID-19 Knowledge, Attitudes, Practices and Perceived Risk: Cross Sectional Mixed Methods
A clinical trial, sponsored by Hunter College of City University of New York.
- Completed
- Registry status
- 148
- Enrollment target
NCT07021716: Completed study, sponsored by Hunter College of City University of New York.
NCT07021716 is a clinical trial that has completed, run by Hunter College of City University of New York. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07021716 has completed, sponsored by Hunter College of City University of New York.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
Knowledge, attitudes, behaviors and perceived risk highlight the importance of education translated into actions to reduce the risk of global infections. The purpose was to investigate the knowledge, attitudes and practices (KAP), and perceived risk associated with COVID-19 among patients with multiple sclerosis (MS), healthcare providers and laypeople during the first 6-months of the pandemic. A descriptive, cross-sectional, partially mixed-methods explanatory sequential design was employed, using convenience sampling. Data were collected through a demographic and a KAP questionnaires including perceived risk assessment. Quantitative data were analyzed with descriptive and inferential statistics, while qualitative comments underwent thematic analysis.
Primary Outcome
Knowledge associated with COVID-19
Interventions
- OTHER No Interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2020-12-30 |
What the finished NCT07021716 record still lists
NCT07021716 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Interventions is the first listed.
NCT07021716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07021716 about?
NCT07021716 is a clinical study titled "COVID-19 Knowledge, Attitudes, Practices and Perceived Risk: Cross Sectional Mixed Methods". Knowledge, attitudes, behaviors and perceived risk highlight the importance of education translated into actions to reduce the risk of global infections. The purpose was to investigate the knowledge, attitudes and practices (KAP), and perceived risk associated with COVID-19 among patients with multi...
What is the current status of trial NCT07021716?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2020-04-01. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT07021716?
The interventions under investigation include: No Interventions (OTHER).
Who is sponsoring clinical trial NCT07021716?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI